Triplet combination of targeted immunotherapeutic agents
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Triplet combination of targeted immunotherapeutic agents, covering 2024-06-18 to 2024-06-18. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents [Phase 2]